FDA approved first drug comprised of an active ingredient derived from marijuana to treat epilepsy
On Jun. 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for…
On Jun. 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for…
On May 24, 2018, the United States Food and Drug Administration (U.S. FDA) released a statement on GR2E…
On Apr. 27, 2018, AquaBounty Technologies announced that it had received approval from the U.S. Food and Drug…
On Mar. 9, 2018, Boston-based cancer company Partner Therapeutics announced that it had acquired the global rights to…
On Jan. 31, 2018, the FDA published the first Red Book, the successor to 1949 “black book,” officially…
On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
On Nov. 9, 2017, Dynavax Technologies announced that the U.S. Food and Drug Administration (FDA) had approved HEPLISAV-B…
On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
On Aug. 24, 2017, Adamas announced U.S. Food and Drug Administration (FDA) approval of GOCOVRI as First and…
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
On Jun. 29, 2017, the U.S. Food and Drug Administration (FDA) unveiled a strategic plan to completely eliminate…
On Jun. 7, 2017 the FDA approved Endari (L-glutamine oral powder) for patients age five years and older…
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On Jul. 12, 2016, Pfizer announced that Prevnar 13ᆴ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received FDA…
On Jun. 15, 2016, the FDA approved revisions in the package insert for YF-Vax to reflect changes to…
On Jun. 10, 2016, the U.S. Food and Drug Administration (FDA) approved Vaxchora, a vaccine for the prevention…
On May 27, 2016, the Food and Drug Administration (FDA) announced it had amended its labeling regulations for…
On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…
On Jun. 14, 2016, the FDA approved changes to vaccine administrationᅠschedule for Trumenba vaccine produced by Wyeth Pharmaceuticals,…